MARX Biotech Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	32.77	74.67	152.83	27.73	0.18
Short-Term Investments	2	3.5	-	-	-
Cash & Short-Term Investments	34.77	78.17	152.83	27.73	0.18
Cash Growth	-55.52%	-48.85%	451.08%	15479.78%	-
Accounts Receivable	67.24	120.02	98.42	54.95	-
Other Receivables	309.24	10.71	4.62	-	-
Receivables	376.48	130.73	103.04	54.95	-
Inventory	115.53	169.88	70	12	-
Prepaid Expenses	12.27	23.57	13.98	0.83	-
Other Current Assets	9.22	4.95	3.19	0.56	-
Total Current Assets	548.27	407.3	343.04	96.07	0.18
Property, Plant & Equipment	209.16	217.19	4.26	4.73	-
Long-Term Investments	-	-	-	-	13.5
Goodwill	20.88	26.25	5.37	-	-
Other Intangible Assets	47.32	65.36	30.1	-	-
Long-Term Deferred Tax Assets	-	6.56	4.92	1.94	0.09
Other Long-Term Assets	7.09	8.54	7.15	0.45	0.03
Total Assets	832.72	731.2	394.85	103.19	13.8
Accounts Payable	51.77	88.88	23.72	5.26	-
Accrued Expenses	56.36	62.76	39.77	12.98	0.5
Short-Term Debt	126.22	98	-	10	-
Current Portion of Long-Term Debt	16.2	5.27	-	-	-
Current Portion of Leases	0.1	3.9	1.26	2.97	-
Current Income Taxes Payable	8.94	-	-	3.41	-
Current Unearned Revenue	37.39	40.26	25.08	2.28	-
Other Current Liabilities	10.9	9.35	11.2	4.6	0.16
Total Current Liabilities	307.88	308.43	101.04	41.5	0.66
Long-Term Debt	164.17	165.04	-	-	-
Long-Term Leases	-	5.11	0.62	0.87	-
Long-Term Deferred Tax Liabilities	1.29	1.38	0.2	0.08	-
Total Liabilities	473.34	479.95	101.86	42.45	0.66
Common Stock	130.5	126.5	124.51	40.8	8.05
Additional Paid-In Capital	184.86	220.48	186.03	17.98	3.21
Retained Earnings	44.02	-95.73	-17.55	1.95	1.89
Shareholders' Equity	359.38	251.25	292.99	60.73	13.14
Total Liabilities & Equity	832.72	731.2	394.85	103.19	13.8
Total Debt	306.69	277.32	1.88	13.84	-
Net Cash (Debt)	-271.92	-199.15	150.94	13.89	0.18
Net Cash Growth	-	-	986.39%	7705.62%	-
Net Cash Per Share	-0.52	-0.40	0.47	0.04	0.01
Filing Date Shares Outstanding	521.98	505.98	498.06	163.21	32.18
Total Common Shares Outstanding	521.98	505.98	498.06	163.21	32.18
Working Capital	240.39	98.87	242.01	54.57	-0.48
Book Value Per Share	0.69	0.50	0.59	0.37	0.41
Tangible Book Value	291.18	159.64	257.52	60.73	13.14
Tangible Book Value Per Share	0.56	0.32	0.52	0.37	0.41
Land	129.46	129.46	-	-	-
Buildings	69.13	9.13	-	-	-
Machinery	10.48	69.13	2.7	1.03	-
Construction In Progress	-	-	0	0.02	-
Leasehold Improvements	5.97	3.75	1.1	0.44	-